Bulk Manufacturer of Controlled Substances Application: Chemtos, LLC, 46907 [2024-11816]
Download as PDF
<![CDATA[
46907
Federal Register / Vol. 89, No. 105 / Thursday, May 30, 2024 / Notices
approved finished dosage forms for
commercial sale.
Chemtos, LLC has applied to
be registered as a bulk manufacturer of
basic class(es) of controlled
substance(s). Refer to Supplementary
Information listed below for further
drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before July 29, 2024. Such persons
may also file a written request for a
hearing on the application on or before
July 29, 2024.
ADDRESSES: The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
SUMMARY:
Marsha L. Ikner,
Acting Deputy Assistant Administrator.
[FR Doc. 2024–11794 Filed 5–29–24; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–1375]
Bulk Manufacturer of Controlled
Substances Application: Chemtos,
LLC
Drug Enforcement
Administration, Justice.
AGENCY:
ACTION:
Notice of application.
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment.
In
accordance with 21 CFR 1301.33(a), this
is notice that on April 10, 2024,
Chemtos, LLC, 16713 Picadilly Court,
Round Rock, Texas 78664–8544,
applied to be registered as a bulk
manufacturer of the following basic
class(es) of controlled substance(s):
SUPPLEMENTARY INFORMATION:
Controlled substance
3-methylmethcathinone (2-(methylamino)-1-(3- methylphenyl)propan-1-one) ...............................................................................
Etizolam (4-(2-chlorophenyl)-2-ethyl-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine ...............................................
Flualprazolam (8-chloro-6-(2-fluorophenyl)-1-methyl-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine) ..........................................
Clonazolam (6-(2-chlorophenyl)-1-methyl-8-nitro-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepin ...................................................
Flubromazolam (8-bromo-6-(2-fluorophenyl)-1-methyl-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine .........................................
Diclazepam (7-chloro-5-(2-chloro-5-(2-chlorophenyl)-1- methyl-1,3-dihydro-2H-benzo[e][1,4]diazepin-2-one ..............................
ADB-BUTINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-butyl-1H-indazole-3-carboxamide) ..............................................
MDMB-4en-PINACA (methyl 3,3-dimethyl-2-(1-(pent-4- en-1-yl)-1H-indazole-3-carboxamido)butanoate) ...................................
4F-MDMB-BUTICA (methyl 2-[[1-(4-fluorobutyl)indole-3- carbonyl]amino]-3,3-dimethyl-butanoate ..............................................
ADB-4en-PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(pent-4-en-1-yl)-1H-indazole-3- carboxamide) .........................
CUMYL-PEGACLONE (5-pentyl-2-(2-phenylpropan-2- yl)pyrido[4,3-b]indol-1-one) .....................................................................
5F-EDMB-PICA (ethyl 2-[[1-(5-fluorophentyl)indole-3- carbonyl]amino]-3,3-dimethyl-butanoate ..................................................
MMB-FUBICA (methyl 2-(1-(4-fluorobenzyl)-1H-indole-3-carboxamido)-3-methyl butanoate .......................................................
a-PiHP (4-methyl-1-phenyl-2-(pyrrolidin-1-yl)pentan-1-one) ..........................................................................................................
The company plans to bulk
manufacture the listed controlled
substances for sale as reference
standards to their customers. No other
activities for these drug codes are
authorized for this registration.
Marsha L. Ikner,
Acting Deputy Assistant Administrator.
[FR Doc. 2024–11816 Filed 5–29–24; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
ddrumheller on DSK120RN23PROD with NOTICES1
[Docket No. DEA–1371]
Bulk Manufacturer of Controlled
Substances Application: AMPAC Fine
Chemicals Virginia LLC
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
AMPAC Fine Chemicals
Virginia LLC has applied to be
SUMMARY:
VerDate Sep<11>2014
20:03 May 29, 2024
Jkt 262001
registered as a bulk manufacturer of
basic class(es) of controlled
substance(s). Refer to SUPPLEMENTARY
INFORMATION listed below for further
drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before July 29, 2024. Such persons
may also file a written request for a
hearing on the application on or before
July 29, 2024.
ADDRESSES: The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
Drug
code
Schedule
1259
2780
2785
2786
2788
2789
7027
7090
7091
7092
7093
7094
7095
7551
I
I
I
I
I
I
I
I
I
I
I
I
I
I
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.33(a), this
is notice that on December 22, 2023,
AMPAC Fine Chemicals Virginia LLC,
2820 Normandy Drive, Petersburg,
Virginia 23805–2380, applied to be
registered as a bulk manufacturer of the
following basic class(es) of controlled
substance(s):
Controlled substance
Amphetamine ..................
Lisdexamfetamine ...........
I
Drug
code
Schedule
1100
1205
II
II
I
The company plans to bulk
manufacture the above listed controlled
substances for the internal use as
intermediates or for distribution to its
customers. No other activities for these
E:\FR\FM\30MYN1.SGM
30MYN1
]]>Agencies
[Federal Register Volume 89, Number 105 (Thursday, May 30, 2024)]
[Notices]
[Page 46907]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-11816]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-1375]
Bulk Manufacturer of Controlled Substances Application: Chemtos,
LLC
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Chemtos, LLC has applied to be registered as a bulk
manufacturer of basic class(es) of controlled substance(s). Refer to
Supplementary Information listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may submit electronic comments on or
objections to the issuance of the proposed registration on or before
July 29, 2024. Such persons may also file a written request for a
hearing on the application on or before July 29, 2024.
ADDRESSES: The Drug Enforcement Administration requires that all
comments be submitted electronically through the Federal eRulemaking
Portal, which provides the ability to type short comments directly into
the comment field on the web page or attach a file for lengthier
comments. Please go to https://www.regulations.gov and follow the
online instructions at that site for submitting comments. Upon
submission of your comment, you will receive a Comment Tracking Number.
Please be aware that submitted comments are not instantaneously
available for public view on https://www.regulations.gov. If you have
received a Comment Tracking Number, your comment has been successfully
submitted and there is no need to resubmit the same comment.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this
is notice that on April 10, 2024, Chemtos, LLC, 16713 Picadilly Court,
Round Rock, Texas 78664-8544, applied to be registered as a bulk
manufacturer of the following basic class(es) of controlled
substance(s):
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
3-methylmethcathinone (2-(methylamino)-1- 1259 I
(3- methylphenyl)propan-1-one).
Etizolam (4-(2-chlorophenyl)-2-ethyl-9- 2780 I
methyl-6H-thieno[3,2-
f][1,2,4]triazolo[4,3-a][1,4]diazepine.
Flualprazolam (8-chloro-6-(2- 2785 I
fluorophenyl)-1-methyl-4H-
benzo[f][1,2,4]triazolo[4,3-
a][1,4]diazepine).
Clonazolam (6-(2-chlorophenyl)-1-methyl- 2786 I
8-nitro-4H-benzo[f][1,2,4]triazolo[4,3-
a][1,4]diazepin.
Flubromazolam (8-bromo-6-(2- 2788 I
fluorophenyl)-1-methyl-4H-
benzo[f][1,2,4]triazolo[4,3-
a][1,4]diazepine.
Diclazepam (7-chloro-5-(2-chloro-5-(2- 2789 I
chlorophenyl)-1- methyl-1,3-dihydro-2H-
benzo[e][1,4]diazepin-2-one.
ADB-BUTINACA (N-(1-amino-3,3-dimethyl-1- 7027 I
oxobutan-2-yl)-1-butyl-1H-indazole-3-
carboxamide).
MDMB-4en-PINACA (methyl 3,3-dimethyl-2- 7090 I
(1-(pent-4- en-1-yl)-1H-indazole-3-
carboxamido)butanoate).
4F-MDMB-BUTICA (methyl 2-[[1-(4- 7091 I
fluorobutyl)indole-3- carbonyl]amino]-
3,3-dimethyl-butanoate.
ADB-4en-PINACA (N-(1-amino-3,3-dimethyl- 7092 I
1-oxobutan-2-yl)-1-(pent-4-en-1-yl)-1H-
indazole-3- carboxamide).
CUMYL-PEGACLONE (5-pentyl-2-(2- 7093 I
phenylpropan-2- yl)pyrido[4,3-b]indol-1-
one).
5F-EDMB-PICA (ethyl 2-[[1-(5- 7094 I
fluorophentyl)indole-3- carbonyl]amino]-
3,3-dimethyl-butanoate.
MMB-FUBICA (methyl 2-(1-(4-fluorobenzyl)- 7095 I
1H-indole-3-carboxamido)-3-methyl
butanoate.
[alpha]-PiHP (4-methyl-1-phenyl-2- 7551 I
(pyrrolidin-1-yl)pentan-1-one).
------------------------------------------------------------------------
The company plans to bulk manufacture the listed controlled
substances for sale as reference standards to their customers. No other
activities for these drug codes are authorized for this registration.
Marsha L. Ikner,
Acting Deputy Assistant Administrator.
[FR Doc. 2024-11816 Filed 5-29-24; 8:45 am]
BILLING CODE P
